Skip to main content

KedRAB Disease Interactions

There are 2 disease interactions with KedRAB (rabies immune globulin, human).

Major

Rabies (applies to KedRAB) antibody response

Major Potential Hazard, High plausibility. Applicable conditions: Immunodeficiency

Patients with primary or acquired deficient/impaired immune response (immunosuppressive therapy, genetic, splenic dysfunction, immunodeficiency disorders) may have reduced antibody response to immunizations. Deferral of immunosuppressive therapy may be considered pending completion of post-exposure therapy unless essential for treatment of other conditions.

References (1)
  1. (2001) "Product Information. Bayrab (rabies immune globulin, human)." Bayer
Moderate

Vaccines (applies to KedRAB) IM injection

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopenia, Thrombocytopathy, Coagulation Defect

In patients with thrombocytopenia or coagulation disorders, IM injections may produce bleeding and hematomas. Patients with a platelet count less than 50,000/mm3 are at an increased risk. Caution is advised if the vaccine (e.g., plague vaccine; hepatitis A and B vaccines; aluminum-adsorbed DTaP, DTP, DT, or Td) must be administered IM. The risk of bleeding may be minimized by vaccination immediately after the administration of replacement factor, use of a 23-gauge (or smaller) needle, and immediate application of direct pressure to the vaccination site for at least 2 minutes.

References (10)
  1. (2001) "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc
  2. "Product Information. Cholera Vaccine (cholera vaccine)." Wyeth-Ayerst Laboratories
  3. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
  4. (2022) "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc
  5. (2005) "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur
  6. (2022) "Product Information. ActHIB (Hib) (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur
  7. (2010) "Product Information. Imogam Rabies-HT (rabies immune globulin, human)." sanofi pasteur
  8. (2015) "Product Information. Hyperrab S/D (rabies immune globulin, human)." Grifols Therapeutics
  9. (2022) "Product Information. Bexsero (meningococcal group B vaccine)." Novartis Vaccines & Diagnostics Inc
  10. (2024) "Product Information. Mresvia Prefilled Syringe (cvx 326) (RSV mRNA vaccine (cvx 326))." Moderna US, Inc

Switch to consumer interaction data

KedRAB drug interactions

There are 25 drug interactions with KedRAB (rabies immune globulin, human).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.